Search
for
Sort by
Research 121–150 of 285
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- Impact of estrogens in males and androgens in females
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- HOTTIP Mediated Therapy Resistance in Glioma Cells Involves Regulation of EMT-Related miR-10b
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Mathematical Modeling and Inference of Epidermal Growth Factor-Induced Mitogen-Activated Protein Kinase Cell Signaling Pathways
- Keratin 79 is a PPARA target that is highly expressed by liver damage
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- PRAME Expression in Mammary and Extramammary Paget Disease
- Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect
- Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
- Regulation and Role of GLI1 in Cutaneous Squamous Cell Carcinoma Pathogenesis
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Survey on adverse events associated with drug therapy for breast cancer patients
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study
- Cancer-Related Alopecia: From Etiologies to Global Management
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
- Selective androgen receptor modulators: a critical appraisal
- Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023